NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
Canada - TSX-V:NLH - CA66980G1090 - Common Stock
0.32 CAD
-0.01 (-3.03%)
NLH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. NLH has an average financial health and profitability rating. NLH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
NLH had negative earnings in the past year.
NLH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
Each year in the past 5 years NLH had a positive operating cash flow.
1.2 Ratios
NLH has a Return On Assets of 0.49%. This is in the better half of the industry: NLH outperforms 64.29% of its industry peers.
The Return On Equity of NLH (0.62%) is better than 71.43% of its industry peers.
With a decent Return On Invested Capital value of 3.34%, NLH is doing good in the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.49% | ||
| ROE | 0.62% | ||
| ROIC | 3.34% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.41%, NLH is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
NLH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 3.04%, NLH is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
NLH has a Gross Margin (39.13%) which is comparable to the rest of the industry.
NLH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.04% | ||
| PM (TTM) | 0.41% | ||
| GM | 39.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NLH is destroying value.
The number of shares outstanding for NLH has been increased compared to 1 year ago.
NLH has more shares outstanding than it did 5 years ago.
NLH has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.62 indicates that NLH is not in any danger for bankruptcy at the moment.
The Altman-Z score of NLH (3.62) is better than 92.86% of its industry peers.
NLH has a debt to FCF ratio of 2.32. This is a good value and a sign of high solvency as NLH would need 2.32 years to pay back of all of its debts.
NLH has a Debt to FCF ratio of 2.32. This is amongst the best in the industry. NLH outperforms 92.86% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that NLH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.04, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 2.32 | ||
| Altman-Z | 3.62 |
ROIC/WACC0.41
WACC8.08%
2.3 Liquidity
NLH has a Current Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of NLH (0.82) is comparable to the rest of the industry.
A Quick Ratio of 0.82 indicates that NLH may have some problems paying its short term obligations.
NLH has a better Quick ratio (0.82) than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.38% over the past year.
Measured over the past years, NLH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.19% on average per year.
Looking at the last year, NLH shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.
NLH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.16% yearly.
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
71.43% of the companies in the same industry are more expensive than NLH, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.14 | ||
| EV/EBITDA | 14.02 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NLH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NLH (11/12/2025, 7:00:00 PM)
0.32
-0.01 (-3.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap27.94M
Revenue(TTM)28.11M
Net Income(TTM)116.10K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.71 | ||
| P/FCF | 14.14 | ||
| P/OCF | 13.89 | ||
| P/B | 1.07 | ||
| P/tB | 24.65 | ||
| EV/EBITDA | 14.02 |
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY7.07%
OCF(TTM)0.02
OCFY7.2%
SpS0.45
BVpS0.3
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.49% | ||
| ROE | 0.62% | ||
| ROCE | 4.39% | ||
| ROIC | 3.34% | ||
| ROICexc | 3.59% | ||
| ROICexgc | 267.42% | ||
| OM | 3.04% | ||
| PM (TTM) | 0.41% | ||
| GM | 39.13% | ||
| FCFM | 5.02% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score5
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 2.32 | ||
| Debt/EBITDA | 0.53 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 5.13 | ||
| Cash Conversion | 92.26% | ||
| Profit Quality | 1214.21% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.62 |
F-Score5
WACC8.08%
ROIC/WACC0.41
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.27%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y-37.45%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%
NOVA LEAP HEALTH CORP / NLH.CA FAQ
Can you provide the ChartMill fundamental rating for NOVA LEAP HEALTH CORP?
ChartMill assigns a fundamental rating of 4 / 10 to NLH.CA.
What is the valuation status for NLH stock?
ChartMill assigns a valuation rating of 2 / 10 to NOVA LEAP HEALTH CORP (NLH.CA). This can be considered as Overvalued.
How profitable is NOVA LEAP HEALTH CORP (NLH.CA) stock?
NOVA LEAP HEALTH CORP (NLH.CA) has a profitability rating of 4 / 10.
What is the financial health of NOVA LEAP HEALTH CORP (NLH.CA) stock?
The financial health rating of NOVA LEAP HEALTH CORP (NLH.CA) is 5 / 10.